Glass Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
43,650
+4,775
+12% +$213K 0.62% 37
2026
Q1
$1.87M Buy
38,875
+2,775
+8% +$129K 0.73% 38
2025
Q4
$1.75M Buy
36,100
+850
+2% +$42.1K 0.72% 40
2025
Q3
$1.66M Buy
35,250
+2,400
+7% +$116K 0.74% 39
2025
Q2
$1.59M Buy
32,850
+925
+3% +$47.3K 0.85% 39
2025
Q1
$1.77M Buy
31,925
+780
+3% +$42.2K 1.06% 36
2024
Q4
$1.5M Buy
31,145
+300
+1% +$15.3K 0.82% 40
2024
Q3
$1.78M Sell
30,845
-260
-0.8% -$14K 0.98% 38
2024
Q2
$1.51M Buy
31,105
+630
+2% +$30.4K 0.88% 39
2024
Q1
$1.48M Buy
+30,475
New +$1.49M 0.9% 37

Other funds holding SNY

Glass Wealth Management's SNY Position: Q2 2026 in Review

Glass Wealth Management increased its Sanofi (SNY) stake by 12% in Q2 2026, buying an estimated $213K and bringing the position to 43,650 shares worth $1.86M. The position accounts for 0.62% of the portfolio, ranked #37.

Glass Wealth Management first reported a position in SNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.87M in Q1 2026. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Glass Wealth Management held 43,650 shares of Sanofi worth $1.86M as of Q2 2026.
  • Glass Wealth Management bought 4,775 Sanofi shares in Q2 2026, an estimated $213K.
  • Sanofi made up 0.62% of Glass Wealth Management's portfolio in Q2 2026, its #37 holding.
  • Glass Wealth Management first reported a position in Sanofi in Q1 2024 and has held it in 10 quarters since.
  • Glass Wealth Management's Sanofi position peaked at $1.87M in Q1 2026.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Glass Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.